Moderna Grant revenue — Total Revenue decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $1.00M to $0.00. Over 3 years (FY 2021 to FY 2025), Grant revenue — Total Revenue shows a downward trend with a -69.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests successful procurement of research funding, while a decrease may indicate the completion of grant-funded projects or reduced external research support.
This represents the total recognized revenue derived from government or private research grants within a specific busine...
Common in biotech and pharmaceutical firms, often compared against total R&D expenditure to gauge the portion of research subsidized by external partners.
mrna_segment_grant_revenue_total_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $139.00M | $140.00M | $262.00M | $126.00M | $183.00M | $144.00M | $24.00M | $28.00M | $44.00M | $0.00 | $0.00 | $176.00M | $7.00M | $10.00M | $1.00M | $5.00M | $14.00M | $2.00M | $0.00 |
| QoQ Change | — | +0.7% | +87.1% | -51.9% | +45.2% | -21.3% | -83.3% | +16.7% | +57.1% | -100.0% | — | — | -96.0% | +42.9% | -90.0% | +400.0% | +180.0% | -85.7% | -100.0% |
| YoY Change | — | — | — | — | +31.7% | +2.9% | -81.0% | -84.7% | -69.4% | — | -100.0% | +528.6% | -84.1% | — | — | -97.2% | +100.0% | -80.0% | -100.0% |